Genetic Technologies: Acquires EasyDNA for $5.4M

Genetic Technologies Acquires EasyDNA for $5.4M

  • Genetic Technologies (GTG) acquires EasyDNA for around $5.4 million in cash and scrip
  • Under the contract, GTG obtains all of Belhealth’s websites, lab testing and distribution agreements associated with its EasyDNA business
  • EasyDNA sells paternity, oncology and health genomics-based laboratory tests, with agreements across 12 labs in North America, Europe and Asia
  • GTG says it will onboard the existing EasyDNA team, retaining the skills of all employees based in Malta and Australia
  • The company says the acquisition will provide it with the foundation to grow its portfolio of serious disease tests across well-established websites in 40 countries
  • The company closed flat at 0.8 cents per share
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

New York Suits Coinbase and Gemini Over Prediction Markets

The state targets two major crypto exchanges regarding regulatory compliance.Highlights: New York has filed lawsuits against Coinbase and...

Cash App Strengthens Parental Control with Managed Accounts for Kids

New feature allows parents to set up and oversee accounts for their children.Highlights: Cash App introduces parent-managed accounts...

Visa and TikTok Launch Creator Card, Enhancing Monetization for Influencers

New financial tool aims to streamline earnings for content creators.Highlights: Visa and TikTok have launched the new Creator...

Nium and Coinbase Strengthen Global Stablecoin Settlement Partnership

The collaboration aims to enhance cross-border payments using stablecoins.Highlights: Nium partners with Coinbase to optimize stablecoin settlements.The collaboration...